Abstract:Abstract Background The role of the vascular endothelial growth factors (VEGFs) in the pathogenesis of Alzheimer’s disease (AD) has been recently described, including notable changes along the VEGFB/FLT1 signaling pathway. Yet, cell‐specific alterations are not well characterized. To disentangle VEGFs’ cell‐specific effect on AD‐related traits, we performed association analyses of mRNA expression from 10 VEGF genes with cognitive performance and AD pathology in eight brain cell types using a large single nucleus RNA sequencing dataset from human brain. Method This project utilized recently published single‐cell transcriptomes derived from dorsolateral prefrontal cortex tissues of 424 donors collected at Rush Alzheimer’s Disease Center. Processed single cell RNA sequencing data were acquired from AD Knowledge Portal (syn2580853). Mean age at death was 89 years, 68% were females, and 37% were AD cases. Negative binomial lognormal mixed models implemented in the NEBULA R package were used to detect differential expression between AD cases and cognitively normal controls, and to analyze the associations with immunohistochemical amyloid and tangles, and finally to assess cross‐sectional and longitudinal global cognitive scores. Correction for multiple comparisons was completed using the false discovery rate procedure (P fdr <0.05). Result Prefrontal cortical FLT1 expression was upregulated in AD participants compared to cognitively normal controls in both endothelial (endo) and microglial (micro) cells. Higher micro‐FLT1, endo‐FLT4, and oligodendrocyte (oligo) VEGFB expression was associated with greater β‐amyloid burden in AD samples, whereas higher VEGFB expression in inhibitory neurons was associated with lower β‐amyloid burden. Higher expression of micro‐FLT1 and oligo‐VEGFB associated with worse cognitive trajectories. Higher micro‐ and endo‐ expression of FLT1 associated with lower cognition scores at the last clinic visit before death. Lastly, higher astrocyte‐expressed NRP1 was associated with lower tangle burden. Conclusion Consistent with our previously reported bulk tissue results, prefrontal cortical expression of FLT1 and FLT4 were associated with global cognition, longitudinal cognitive trajectories, and AD neuropathology, and these associations appear to be limited to endothelial and microglial cells. In contrast, VEGFB expression seems to have opposite effects on amyloid burden depending on the cell types, suggesting its more dynamic role in AD physiopathology.

Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease.

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients

RETRACTED: Effect of VEGF on neuronal degeneration and interaction between Alzheimer's disease biomarkers(Retracted article. See vol.21,pg.3982,2017)

Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease

[Expression of Vascular Endothelial Growth Factor and Microvessel Density in Hippocampus of Rats with Aging].

Vascular endothelial growth factor is an effective biomarker for vascular dementia, not for Alzheimer's disease: A meta-analysis

Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum.

Dynamic Changes in Vascular Size and Density in Transgenic Mice with Alzheimer's Disease.

Association of 10 VEGF Family Genes with Alzheimer's Disease Endophenotypes at Single Cell Resolution

Single‐cell Transcriptomes Reveal Cell‐type Specific Roles of VEGF Family Genes in the Pathogenesis of Alzheimer’s Disease

Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Association of ten VEGF family genes with Alzheimer's disease endophenotypes at single cell resolution

VEGF-induced Angiogenesis Ameliorates the Memory Impairment in APP Transgenic Mouse Model of Alzheimer’s Disease

Visual Abnormalities Associate With Hippocampus In Mild Cognitive Impairment And Early Alzheimer'S Disease

Elevated Plasma Angiogenesis Factors in Alzheimer's Disease.

[A Study on Expression of HIF-1alpha and EPO in the Hippocampus of Rats with Vascular Dementia].

[Expression of Vascular Endothelial Growth Factor and Microvessel Density in Different Brain Regions in Aged Rats].

Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer’s disease

High-resolution Mapping of Brain Vasculature and Its Impairment in the Hippocampus of Alzheimer's Disease Mice

Plasma Level of Endothelin-1 and Vascular Endothelial Growth Factor in Vascular Congnitive Impairment and Dementia